Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
KEYNOTE-158 trial
.
Show all posts
Showing posts with label
KEYNOTE-158 trial
.
Show all posts
Wednesday, June 13, 2018
KEYTRUDA gains FDA approval for treatment of recurrent or metastatic cervical cancer
›
The U.S. Food and Drug Administration (FDA) has approved Merck’s pembrolizumab (KEYTRUDA®), for the treatment of patients with recurrent...
2 comments:
›
Home
View web version
